Vitamin D3 for Life

Live Enlightened

Article

Why Normal 1,25-Dihydroxyvitamin D Does Not Rule Out Low Vitamin D Status

Previous related pageWhy Free and Total Vitamin D Can Diverge Between PeopleNext related pageWhy Vitamin D and Iron Results Differ Between Populations
Study at a glance

Can active vitamin D be normal when the usual blood test shows a low level?

Yes. A normal 1,25-dihydroxyvitamin D result, which measures the active hormone, does not rule out low 25-hydroxyvitamin D, the main form measured in the usual vitamin D blood test.

Why can the active hormone stay normal?

The body controls active vitamin D to help maintain calcium balance. Parathyroid hormone, which helps control blood calcium, can encourage the kidneys to change more of the available 25-hydroxyvitamin D into active hormone.

Will active vitamin D always stay normal during deficiency?

No. When vitamin D supplies become very low, there may be too little starting material for the body to make up for the shortfall in this way. Kidney problems and other problems controlling mineral levels can also change the active-hormone result.

Which blood test usually checks vitamin D supply?

Total 25-hydroxyvitamin D is the usual blood test for checking vitamin D supply. Active vitamin D testing answers different, more specialised questions and does not show whether every tissue has adequate vitamin D activity.

Read the full article below ↓

A normal active-vitamin-D result can look reassuring, especially when 1,25-dihydroxyvitamin D is described as the hormonally active form. But the body does not use circulating 1,25(OH)₂D as a passive reflection of its vitamin D stores. It regulates the active hormone aggressively. That is why a person can have low circulating 25(OH)D while 1,25(OH)₂D remains within the laboratory reference range.

The apparent contradiction comes from measuring two different layers of physiology

25(OH)D is the larger circulating substrate pool. It is formed mainly in the liver and is the biomarker normally used when vitamin D status needs to be assessed. 1,25(OH)₂D is produced mainly by the kidney and functions as an endocrine hormone. Its concentration is controlled according to mineral and hormonal signals, so it can be defended even when the substrate pool is declining.

This is the central distinction behind Vitamin D Testing: 25-OH-D vs 1,25-OH₂-D. “Active” does not mean “best marker of how much vitamin D is available.” It means the metabolite sits at the hormone-output end of the pathway.

PTH can help preserve active hormone as 25(OH)D falls

When calcium availability is threatened, parathyroid hormone can stimulate renal CYP27B1, the enzyme that converts 25(OH)D into 1,25(OH)₂D. This is a homeostatic response: the body can increase the fraction of available substrate being activated in order to preserve calcium absorption and mineral balance. A falling 25(OH)D pool therefore does not have to produce an immediate fall in circulating active hormone.

A primary clinical study by Need and colleagues makes this visible. Among 319 patients with 25(OH)D at or below 40 nmol/L, active hormone and calcium absorption were maintained across much of the low-status range. The active-hormone result therefore looked comparatively preserved while the status marker was already low.

The compensation is real, but it is not unlimited

In the same dataset, the pattern changed in the most severely depleted group. When 25(OH)D was 10 nmol/L or lower, 1,25(OH)₂D and calcium absorption were lower and PTH was higher. At that point, substrate availability appeared too limited for homeostatic stimulation to maintain active-hormone production fully.

This prevents two opposite mistakes. It is wrong to say that low vitamin D status must produce low 1,25(OH)₂D immediately. It is also wrong to say that 1,25(OH)₂D will always stay normal or high in deficiency. The result depends on the severity of substrate depletion and on the renal and endocrine systems doing the regulating.

Kidney function and mineral hormones can shift the relationship further

Because the kidney is the major source of circulating 1,25(OH)₂D, impaired renal activation can lower the active hormone even if 25(OH)D is available. FGF23 can suppress renal activation, while PTH can stimulate it. Disorders involving calcium or phosphate balance can therefore change the relationship between the two blood tests. Vitamin D and Kidneys provides the wider renal context for that regulation.

A normal circulating active hormone also does not prove normal tissue signalling

Some tissues can convert 25(OH)D to 1,25(OH)₂D locally. This local production may act within or near the tissue without materially changing the amount of active hormone measured in blood. Conversely, a normal circulating active-hormone result does not show that every tissue is receiving or responding to the same signal.

This is why Vitamin D Status vs Vitamin D Effect matters. A blood concentration is a useful measurement, but biological effect depends on activation, degradation, receptor biology and tissue context as well.

“Active” describes biological role, not usefulness as a status marker

The terminology itself creates much of the confusion. 1,25(OH)₂D is called active because it is the high-affinity hormonal ligand that drives vitamin D receptor signalling. That does not mean its circulating concentration is the best way to estimate the amount of vitamin D available in the body. Hormones are often regulated precisely because their biological effects are powerful; their concentration can therefore be maintained by feedback even while the upstream substrate pool changes.

25(OH)D is less biologically active but more useful for the different task of status assessment. It is the major circulating metabolite, exists at much higher concentrations, and is more closely tied to the substrate supplied by skin synthesis, diet and supplementation. The two labels therefore describe different biological jobs rather than a ranking of which blood test is more informative in every setting.

What a normal 1,25(OH)₂D result can and cannot tell you

  • It can describe the circulating concentration of the active endocrine metabolite at the time of sampling.
  • It can be informative in selected disorders of renal activation, vitamin D resistance, inappropriate extra-renal production and phosphate regulation.
  • It cannot by itself establish that the circulating 25(OH)D status pool is adequate.
  • It cannot by itself rule out low vitamin D status.
  • It cannot be assumed to remain normal in extreme substrate depletion or impaired renal activation.
  • It does not measure the totality of local tissue activation or downstream vitamin D effect.

The useful mental model is substrate versus regulated output

The simplest way to avoid the confusion is to think of 25(OH)D as the main circulating substrate/status pool and 1,25(OH)₂D as a regulated hormonal output. The output can be defended for a time even while the pool shrinks, just as other endocrine systems can preserve a controlled variable by increasing regulatory effort. Eventually, however, severe substrate limitation or impaired organ function can constrain that compensation.

This model is more accurate than reading one result in isolation, and it explains why the “active” form is not automatically the most informative test of vitamin D status.

Primary evidence and source details

Vitamin D Metabolites and Calcium Absorption in Severe Vitamin D Deficiency. Need AG et al. Journal of Bone and Mineral Research. 2008;23:1859 to 1863.

Vitamin D Assays. Bikle DD. Frontiers of Hormone Research. 2018;50:14 to 30.

The When, What & How of Measuring Vitamin D Metabolism in Clinical Medicine. Dirks NF et al. Nutrients. 2018;10:482.

Related reading

Original sources

Source

Vitamin D Assays

Published in Bikle DD. Frontiers of Hormone Research (2018).

Publication details

Vitamin D Assays. Bikle DD. Frontiers of Hormone Research. 2018;50:14 to 30.

Read more →